Skip to main navigation Skip to search Skip to main content

Correction to: Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer (Breast Cancer Research and Treatment, (2025), 210, 3, (783-790), 10.1007/s10549-025-07615-8)

  • University of Limerick
  • University Hospitals Limerick

Research output: Contribution to journalComment/debate

Abstract

In this article, James A.L. Brown at affiliations ‘Department of Biological Sciences, University of Limerick, Galway, Ireland’ and ‘Limerick Digital Cancer Research Centre (LDCRC), University of Limerick, Limerick, Ireland’ was missing from the author list. The original article has been corrected.

Original languageEnglish
Pages (from-to)759
Number of pages1
JournalBreast Cancer Research and Treatment
Volume211
Issue number3
DOIs
Publication statusPublished - Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction to: Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer (Breast Cancer Research and Treatment, (2025), 210, 3, (783-790), 10.1007/s10549-025-07615-8)'. Together they form a unique fingerprint.

Cite this